Michael J. Ackerman, M.D., PhD is the Windland Smith Rice Cardiovascular Genomics Research Professor and Professor of Medicine, Pediatrics, and Pharmacology at the Mayo Clinic in Rochester, Minnesota. Dr Ackerman was born and raised in Iowa. He graduated valedictorian from Sheldon High School in 1984, and in 1988, he graduated summa cum laude from Luther College in Decorah, Iowa majoring in chemistry and mathematics. He received his M.D. and PhD degrees from the Mayo Clinic Alix School of Medicine and the Mayo Clinic Graduate School of Biomedical Sciences in 1995 and completed residency (pediatrics) and fellowship (pediatric cardiology) training in the Mayo Clinic Graduate School of Medicine in 2000.
He has been a faculty member of Mayo Clinic since July 2000 and has served as President of the Sudden Arrhythmia Death Syndromes (SADS) Foundation since 2006. In 2018, he received the Heart Rhythm Society’s Distinguished Scientist Award, and in 2021, he was inducted into the Association of American Physicians. He was named Mayo Clinic’s Distinguished Clinician in 2015 and its Distinguished Investigator in 2021.
As Director of Mayo Clinic’s Windland Smith Rice Genetic Heart Rhythm Clinic and Sudden Death Genomics Laboratory, Dr Michael Ackerman strives to fulfil the two-fold objective of medical education and biomedical research as stated by Dr Charles H. Mayo: “to heal the sick and to advance the science.
We wish to acknowledge Perth Business Events, destination partner for 2024, for their support of this speaker
The RT Hall Lecture:
RT Hall came to Sydney from England in 1853 on the vessel “Waterloo”. He was consumptive but managed to survive the long voyage and made a complete recovery His affairs flourished and when he died in 1894, he established a trust initially for: “An invalid home for the reception, cure and treatment of culture for respectable, moral persons, residing in Sydney or its suburbs, and suffering from consumption of the lungs”. A sanitarium was established in the Blue Mountains in 1909 and was active till the early 1950s when the treatment of tuberculosis radically changed. The trust then looked for an alternative field to support and became involved in The National Heart Foundation. In 1959 and for a number of years, the bequest supported the RT Hall Lecturer. In more recent times, the bequest has supported the RT Hall Prize and the lectureship has been funded by a donation from The National Heart Foundation.Back to speakers